Skip to main content
Clinical Trials/NL-OMON53316
NL-OMON53316RecruitingNot Applicable

ongitudinal Early Epilepsy Study - LEES

Medisch Universitair Ziekenhuis Maastricht0 sites75 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
75

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
2 to 17 (—)

Inclusion Criteria

  • 1. Primarily presented with daily occurring episodes of brief loss of
  • consciousness (absences) in an otherwise normal child in the previous 2 years.
  • 2. An EEG showing 3 Hz (2.5-4.5 Hz) generalized rythmic spike-and-wave
  • complexes with a discharge duration of at least 3 seconds on a present or
  • former EEG.
  • 3. Early absence epilepsy , defined as a confirmed diagnosis or seizures within
  • 4. Aged 6-12 years at inclusion
  • 5. Permitted accompanying factors:
  • - A few generalized tonic-clonic seizures (assessed individually according to
  • ILAE statements);
  • - Mild myoclonic eye(lid) movements
  • - Co-morbidities: Attention deficiency/concentration disorders, autism,
  • dyslexia and anxiety. These do not form exclusion criteria as this is
  • frequently seen in children with absence seizures and it might be uncertain if
  • the co-morbidity is a manifestation of the absence epilepsy., Age-gender
  • matched controls
  • - Overall healthy (do not have any of the exclusion criteria) and following a
  • regular school without major problems, which makes a normal intelligence
  • - Aged 6-12 years on inclusion

Exclusion Criteria

  • * A diagnosis according to ILAE criteria of the following epilepsy syndromes:
  • Juvenile Absence Epilepsy; Eylide myoclonia with absences; Dravet syndrome;
  • Epilepsy with myoclonic-atonic seizures; Epilepsy with Myoclonic Absences;
  • Lennox-Gastaut syndrome; Frontal Lobe Epilepsy or other focal epilepsy.
  • * A confirmed diagnosis of epilepsy/seizures for more than 2 years (58).
  • * Recent hospitalizations in the last months or a history which might limit
  • participation in or completion of the study protocol.
  • * Behavioural characteristics which might hamper the gathering of useful MRI
  • * Intellectual disability or other diseases/causes that may underlie cognitive
  • impairment (i.e. neurodegenerative diseases).
  • * History of major head trauma or head/brain surgery.
  • * MRI lesions on (previous) structural brain MRI- or CT-scans or symptomatic
  • epilepsies (e.g. epilepsy related to tumours, vascular abnormalities,
  • congenital dysgenesia).
  • * MRI contra-indications: claustrophobia, anxiety for an MRI scan, or presence
  • of metallic objects (e.g. prostheses, pacemakers, metal clips on blood vessels,
  • metal parts in the eye). Dental braces are no exclusion criterion for absence
  • * Regularly using drugs of abuse (asked during screening session).
  • * Parents or participants (aged*12 years) not willing to provide informed
  • * Parents or participants (aged*12 years) who do not want to get informed
  • whenever structural abnormalities are found during imaging.

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Similar Trials